Serum 25-hydroxyvitamin D is associated with enhanced pneumococcal antibody levels in individuals with asthma

Allergy and Asthma Proceedings

Volumn 32, Issue 6, 2011, Pages 445-452

  Lee, Jusuk ^a,b   Zhao, Hongxia ^a,c   Fenta, Yilma ^a   Kita, Hirohito ^a   Kumar, Rajiv ^a   Juhn, Young J ^a  

^a MAYO CLINIC   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BACTERIUM ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 6; PNEUMOCOCCAL ANTIBODY; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANTIBODY TITER; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; MALE; SENSITIZATION; STREPTOCOCCUS PNEUMONIA; VITAMIN BLOOD LEVEL;

ADULT; ANTIBODIES, BACTERIAL; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; MALE; MIDDLE AGED; STREPTOCOCCUS PNEUMONIAE; VITAMIN D; YOUNG ADULT;

EID: 84455188404     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3494     Document Type: Article

References (47)

1. Rajakumar K, and Thomas SB. Reemerging nutritional rickets: a historical perspective. Arch Pediatr Adolesc Med 159:335-341, 2005. (Pubitemid 40489175)
2. Elliott ME, Binkley NC, Carnes M, et al. Fracture risks for women in long-term care: High prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy 23:702-710, 2003. (Pubitemid 36629073)
3. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353-373, 2006. (Pubitemid 43334631)
4. Kim DH, Sabour S, Sagar UN, et al. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 102:1540-1544, 2008.
5. Ginde AA, Liu MC, and Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 169:626-632, 2009.
6. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25- Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909-2912, 2004. (Pubitemid 39141992)
7. Ginde AA, Mansbach JM, and Camargo CA Jr. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep 9:81-87, 2009.
8. Liu PT, Stenger S, Tang DH, and Modlin RL. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179:2060-2063, 2007.
9. Baeke F, Takiishi T, Korf H, et al. Vitamin D: Modulator of the immune system. Curr Opin Pharmacol 10:482-496, 2010.
10. White AN, Ng V, Spain CV, et al. Let the sun shine in: Effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, Pennsylvania. BMC Infect Dis 9:196, 2009.
11. Griffioen AW, Toebes EA, Rijkers GT, et al. The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide. Immunol Lett 32:265-272, 1992.
12. Khan AQ, Lees A, and Snapper CM. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help. J Immunol 172:532-539, 2004. (Pubitemid 38020510)
13. Khan AQ, Shen Y, Wu ZQ, et al. Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun 70:749-761, 2002. (Pubitemid 34083837)
14. Jung JA, Kita H, Dhillon R, et al. Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgrad Med 122:116-124, 2010.
15. Lee HJ, Kang JH, Henrichsen J, et al. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine 13:1533-1538, 1995.
16. Arkwright PD, Patel L, Moran A, et al. Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine. Clin Exp Immunol 122:16-19, 2000.
17. Laaksi I, Ruohola JP, Tuohimaa P, et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 86:714-717, 2007. (Pubitemid 47435839)
18. Leow L, Simpson T, Cursons R, et al. Vitamin D, innate immunity and outcomes in community acquired pneumonia. Respirology 16:611-616, 2011.
19. Li-Ng M, Aloia JF, Pollack S, et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 137:1396-1404, 2009.
20. Juhn YJ, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol 122:719-723, 2008.
21. Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: A longitudinal household study. J Infect Dis 192:387-393, 2005. (Pubitemid 41023116)
22. Hanania NA, Sockrider M, Castro M, et al. Immune response to influenza vaccination in children and adults with asthma: Effect of corticosteroid therapy. J Allergy Clin Immunol 113:717-724, 2004. (Pubitemid 38530429)
23. Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: A longitudinal household study. J Infect Dis 192:387-393, 2005. (Pubitemid 41023116)
24. Jacob GL, and Homburger HA. Simultaneous quantitative measurement of IgG antibodies to Streptococcus pneumoniae serotypes by microsphere photomometry. J Allergy Clinical Immunol 113:S288, 2004.
25. Sorensen RU, Leiva LE, Javier FC III, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 102:215-221, 1998. (Pubitemid 28406908)
26. Roth HJ, Schmidt-Gayk H, Weber H, and Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 45:153-159, 2008. (Pubitemid 351724586)
27. Kriesel JD, and Spruance J. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 17:1883-1888, 1999. (Pubitemid 29172356)
28. Frieri M. The role of vitamin D in asthmatic children. Curr Allergy Asthma Rep 11:1-3, 2011.
29. Taylor CE, and Camargo CA Jr. Impact of micronutrients on respiratory infections. Nutr Rev 69:259-269, 2011.
30. Zhou Y, Zhou X, and Wang X. 1,25-Dihydroxyvitamin D3 prevented allergic asthma in a rat model by suppressing the expression of inducible nitric oxide synthase. Allergy Asthma Proc 29:258-267, 2008.
31. Ginde AA, Mansbach JM, and Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169:384-390, 2009.
32. Brehm JM, Schuemann B, Fuhlbrigge AL, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol 126:52-58, 2011.
33. Pincikova T, Nilsson K, Moen IE, et al. Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr 65:102-109, 2011.
34. Chambers ES, and Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep 11:29-36, 2011.
35. Heine G, Niesner U, Chang HD, et al. 1,25-Dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 38:2210-2218, 2008.
36. Taher YA, van Esch BC, Hofman GA, et al. 1Alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: Role for IL-10 and TGF-beta. J Immunol 180:5211-5221, 2008.
37. Jorde R, Sneve M, Torjesen PA, et al. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50:175-180, 2010.
38. Pichler J, Gerstmayr M, Szepfalusi Z, et al. 1 Alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 52:12-18, 2002. (Pubitemid 34665944)
39. Almirall J, Bolibar I, Serra-Prat M, et al. New evidence of risk factors for community-acquired pneumonia: A population-based study. Eur Respir J 31:1274-1284, 2008.
40. Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 352:2082-2090, 2005. (Pubitemid 40667531)
41. Sanderson P, Elsom RL, Kirkpatrick V, et al. UK food standards agency workshop report: Diet and immune function. Br J Nutr 103:1684-1687, 2010.
42. Slomski A. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 305:453-454, 456, 2011.
43. Riegelman RK. What to do until the FDA arrives. Postgrad Med 70:103-108, 1981. (Pubitemid 12171089)
44. Di Nardo A, Vitiello A, and Gallo RL. Cutting edge: Mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 170:2274-2278, 2003. (Pubitemid 36245611)
45. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773, 2006.
46. Yamshchikov AV, Kurbatova EV, Kumari M, et al. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 92:603-611, 2010.
47. Oduwole AO, Renner JK, Disu E, et al. Relationship between vitamin D levels and outcome of pneumonia in children. West Afr J Med 29:373-378, 2010.